Hodgkin Lymphoma — Trials

Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

972 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 179
Recruiting: 90
Ph III recruiting: 6
Growth YoY: −4.2%
Industry share: 11%
Top sponsor: City of Hope Medical Center
Termination share: 27.7%
Trials / 1,000 deaths: 175.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (145)

clinicaltrialsPublishedShowing 51–56 of 56 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01188798	Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies	completed	Phase 3	6	St. Jude Children's Research HospitalOTHER	1	Mar 21, 2013	clinicaltrials
NCT00799461	Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications	completed	Phase 3	1,337	Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium